Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Metlife (MET-PF) over the last 17 years, with Q3 2025 value amounting to $3.0 billion.

  • Metlife's Receivables - Other rose 787.09% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 787.09%. This contributed to the annual value of $2.8 billion for FY2024, which is 763.89% up from last year.
  • As of Q3 2025, Metlife's Receivables - Other stood at $3.0 billion, which was up 787.09% from $3.0 billion recorded in Q2 2025.
  • Metlife's 5-year Receivables - Other high stood at $3.0 billion for Q2 2025, and its period low was $150.0 million during Q1 2022.
  • In the last 5 years, Metlife's Receivables - Other had a median value of $2.6 billion in 2021 and averaged $2.3 billion.
  • As far as peak fluctuations go, Metlife's Receivables - Other tumbled by 9207.64% in 2021, and later skyrocketed by 106520.0% in 2024.
  • Metlife's Receivables - Other (Quarter) stood at $2.6 billion in 2021, then dropped by 6.73% to $2.5 billion in 2022, then rose by 5.71% to $2.6 billion in 2023, then grew by 7.64% to $2.8 billion in 2024, then grew by 6.59% to $3.0 billion in 2025.
  • Its Receivables - Other was $3.0 billion in Q3 2025, compared to $3.0 billion in Q2 2025 and $2.9 billion in Q1 2025.